The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc's drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday.
Lexicon, which plans to launch the drug by the end of June, said the medicine's wholesale price is expected to be on par with existing branded heart failure medications.
Sotagliflozin presents a unique proposition in heart failure, especially considering the drug's differentiated benefit in hospitalized patients, compared with existing treatments, Piper Sandler analyst Yasmeen Rahimi said ahead of the approval.Lexicon partnered with French drugmaker Sanofi SA
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
TransCon PTH Nears US Approval for Hypoparathyroidism?Palopegteriparatide is a potential long-term therapy for adults with hypoparathyroidism, new findings suggest.
Leer más »
COVID-19 pill Paxlovid gets full FDA approval after over a year of emergency useThursday’s action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely.
Leer más »
Paxlovid, Pfizer's COVID-19 pill, gets full FDA approvalU.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid.
Leer más »
Elon Musk’s Neuralink gets FDA approval for human test of brain implantsNeuralink is developing a brain implant it hopes will help paralyzed people walk again and cure other neurological ailments.
Leer más »
Elon Musk's Neuralink gets FDA approval for study of brain implants in humansElon Musk's brain-implant company Neuralink on Thursday said it had received the U.S. Food and Drug Administration's (FDA) approval to launch its first-in-human clinical study.
Leer más »
Pfizer's Paxlovid still free, for now, after FDA grants full approval to COVID drugThe Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the FDA granted Pfizer full approval Thursday to market the pills.
Leer más »